Daisuke Ito

Summary

Affiliation: University of Minnesota
Country: USA

Publications

  1. pmc Canine lymphoma as a comparative model for human non-Hodgkin lymphoma: recent progress and applications
    Daisuke Ito
    Department of Veterinary Clinical Sciences, University of Minnesota, St Paul, MN, USA Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA Electronic address
    Vet Immunol Immunopathol 159:192-201. 2014
  2. pmc CD40 ligand is necessary and sufficient to support primary diffuse large B-cell lymphoma cells in culture: a tool for in vitro preclinical studies with primary B-cell malignancies
    Daisuke Ito
    Masonic Cancer Center, University of Minnesota, Minneapolis, MN 5455, USA
    Leuk Lymphoma 53:1390-8. 2012
  3. pmc Exclusion of cytoplasmic fragments in flow cytometric analysis of lymph node samples from dogs with lymphoma using membrane-permeable violet laser-excitable DNA-binding fluorescent dye (DyeCycle Violet)
    Daisuke Ito
    Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA
    Vet Clin Pathol 39:494-8. 2010
  4. pmc A tumor-related lymphoid progenitor population supports hierarchical tumor organization in canine B-cell lymphoma
    D Ito
    Department of Veterinary Clinical Sciences, College of Veterinary Medicine, University of Minnesota, St Paul, MN, USA
    J Vet Intern Med 25:890-6. 2011
  5. pmc Isolation and characterization of canine natural killer cells
    Helen T Michael
    Department of Veterinary Clinical Sciences, College of Veterinary Medicine, University of Minnesota, 1352 Boyd Avenue, St Paul, MN 55108, United States
    Vet Immunol Immunopathol 155:211-7. 2013
  6. ncbi request reprint Constitutive activation of alternative nuclear factor kappa B pathway in canine diffuse large B-cell lymphoma contributes to tumor cell survival and is a target of new adjuvant therapies
    Davis M Seelig
    a Department of Veterinary Clinical Sciences, College of Veterinary Medicine, University of Minnesota, St Paul, MN, USA
    Leuk Lymphoma . 2016
  7. pmc Parenchymal signal intensity in 3-T body MRI of dogs with hematopoietic neoplasia
    Daniel A Feeney
    Department of Veterinary Clinical Sciences, University of Minnesota, St Paul, Minnesota, USA
    Comp Med 63:174-82. 2013
  8. pmc Molecular characterization of canine BCR-ABL-positive chronic myelomonocytic leukemia before and after chemotherapy
    Sarah Culver
    Department of Molecular Biomedical Sciences, College of Veterinary Medicine, North Carolina State University, Raleigh, NC, USA
    Vet Clin Pathol 42:314-22. 2013
  9. pmc Stage-specific embryonic antigen (SSEA): determining the expression in canine glioblastoma, melanoma, and mammary cancer cells
    Weiming Lin
    Department of Veterinary Clinical Sciences and Masonic Cancer Center, University of Minnesota, Minneaplis, MN 55455, USA
    J Vet Sci . 2016
  10. pmc Development of a novel anti-canine CD20 monoclonal antibody with diagnostic and therapeutic potential
    Daisuke Ito
    Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA
    Leuk Lymphoma 56:219-25. 2015

Detail Information

Publications10

  1. pmc Canine lymphoma as a comparative model for human non-Hodgkin lymphoma: recent progress and applications
    Daisuke Ito
    Department of Veterinary Clinical Sciences, University of Minnesota, St Paul, MN, USA Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA Electronic address
    Vet Immunol Immunopathol 159:192-201. 2014
    ....
  2. pmc CD40 ligand is necessary and sufficient to support primary diffuse large B-cell lymphoma cells in culture: a tool for in vitro preclinical studies with primary B-cell malignancies
    Daisuke Ito
    Masonic Cancer Center, University of Minnesota, Minneapolis, MN 5455, USA
    Leuk Lymphoma 53:1390-8. 2012
    ..We conclude that this system has broad applications for in vitro preclinical development for B-cell malignancies...
  3. pmc Exclusion of cytoplasmic fragments in flow cytometric analysis of lymph node samples from dogs with lymphoma using membrane-permeable violet laser-excitable DNA-binding fluorescent dye (DyeCycle Violet)
    Daisuke Ito
    Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA
    Vet Clin Pathol 39:494-8. 2010
    ..These cytoplasmic fragments interfere with accurate gating of target cells and quantification protocols used for flow cytometry because of their variable size and expression of lymphoid cell surface antigens on their membranes...
  4. pmc A tumor-related lymphoid progenitor population supports hierarchical tumor organization in canine B-cell lymphoma
    D Ito
    Department of Veterinary Clinical Sciences, College of Veterinary Medicine, University of Minnesota, St Paul, MN, USA
    J Vet Intern Med 25:890-6. 2011
    ..This model is clinically important, as TICs are promising targets for cancer therapies. However, TICs in spontaneous B-cell lymphoma have not been conclusively identified...
  5. pmc Isolation and characterization of canine natural killer cells
    Helen T Michael
    Department of Veterinary Clinical Sciences, College of Veterinary Medicine, University of Minnesota, 1352 Boyd Avenue, St Paul, MN 55108, United States
    Vet Immunol Immunopathol 155:211-7. 2013
    ..The data show that cells meeting the criteria for NK cells in other species, i.e., non-T, non-B lymphocytes with cytotoxic activity, can be expanded from canine PBMC by T-cell depletion and culture with cytokines or feeder cells. ..
  6. ncbi request reprint Constitutive activation of alternative nuclear factor kappa B pathway in canine diffuse large B-cell lymphoma contributes to tumor cell survival and is a target of new adjuvant therapies
    Davis M Seelig
    a Department of Veterinary Clinical Sciences, College of Veterinary Medicine, University of Minnesota, St Paul, MN, USA
    Leuk Lymphoma . 2016
    ..In conclusion, the ANFκBP facilitates survival of canine DLBCL cells, and thus, dogs with spontaneous DLBCL can provide a useful large animal model to study therapies targeting the ANFκBP...
  7. pmc Parenchymal signal intensity in 3-T body MRI of dogs with hematopoietic neoplasia
    Daniel A Feeney
    Department of Veterinary Clinical Sciences, University of Minnesota, St Paul, Minnesota, USA
    Comp Med 63:174-82. 2013
    ....
  8. pmc Molecular characterization of canine BCR-ABL-positive chronic myelomonocytic leukemia before and after chemotherapy
    Sarah Culver
    Department of Molecular Biomedical Sciences, College of Veterinary Medicine, North Carolina State University, Raleigh, NC, USA
    Vet Clin Pathol 42:314-22. 2013
    ..Further understanding of the genetic aberrations involved in canine leukemia may be crucial to improve treatment protocols...
  9. pmc Stage-specific embryonic antigen (SSEA): determining the expression in canine glioblastoma, melanoma, and mammary cancer cells
    Weiming Lin
    Department of Veterinary Clinical Sciences and Masonic Cancer Center, University of Minnesota, Minneaplis, MN 55455, USA
    J Vet Sci . 2016
    ..Our results document, for the first time, the expression of SSEA-1 in multiple types of canine cancer lines...
  10. pmc Development of a novel anti-canine CD20 monoclonal antibody with diagnostic and therapeutic potential
    Daisuke Ito
    Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA
    Leuk Lymphoma 56:219-25. 2015
    ..In summary, we have established a novel anti-canine CD20 mAb that is useful as a diagnostic tool to phenotype B-cells, and which could be integrated as a tool for passive immunotherapy to treat dogs with B-cell disorders...